Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Naproxen (Aleve)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 36Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aleve® Speaks The Painful Truth, Encouraging Consumers to Explore
    Aleve® Speaks The Painful Truth, Encouraging Consumers to Explore

    25 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240325938118/en

    BUSINESSWIRE
    25 Mar 2024
    Share Share
    Patheon's Generic Naproxen Sodium Receives Approval in the U.S.
    Patheon's Generic Naproxen Sodium Receives Approval in the U.S.

    10 Jan 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214463

    FDA
    10 Jan 2023
    Share Share
    Hetero's Generic Naproxen Sodium Receives Approval in the U.S.
    Hetero's Generic Naproxen Sodium Receives Approval in the U.S.

    28 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211065

    FDA
    28 Oct 2022
    Share Share
    Strides Pharma gets USFDA nod for anti-inflammatory drug
    Strides Pharma gets USFDA nod for anti-inflammatory drug

    18 Aug 2022

    // BUSINESS-STANDARD

    https://www.business-standard.com/article/news-cm/strides-pharma-gets-usfda-nod-for-anti-inflammatory-drug-122081800747_1.html

    BUSINESS-STANDARD
    18 Aug 2022
    Share Share
    Strides' Generic Naproxen Sodium Receives Approval in the U.S.
    Strides' Generic Naproxen Sodium Receives Approval in the U.S.

    17 Aug 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215472

    FDA
    17 Aug 2022
    Share Share
    Aurobindo's Generic Naproxen :Pseudoephedrine HCL Receives Approval in the U.S.
    Aurobindo's Generic Naproxen :Pseudoephedrine HCL Receives Approval in the U.S.

    01 Jun 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211360

    FDA
    01 Jun 2022
    Share Share